Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L, Dietsche I, Kießler M, Sommer U, Muckenhuber A, Steiger K, van Eijck CWF, Richter L, Istvanffy R, Jäger C, Friess H, van Eijck CHJ, Demir IE, Reyes CM, Schmitz M.
Rupp L, et al. Among authors: reyes cm.
Front Immunol. 2024 Apr 2;15:1378190. doi: 10.3389/fimmu.2024.1378190. eCollection 2024.
Front Immunol. 2024.
PMID: 38629072
Free PMC article.